Haruka Mori
Tsukuba, 3058575, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation.
Journal: Scientific reports
Published: October 21, 2023
Electrical, structural, and autonomic atrial remodeling underlies atrial fibrillation in inflammatory atrial cardiomyopathy.
Journal: Frontiers in cardiovascular medicine
Published: October 20, 2022
Increased angiotensin II coupled with decreased Adra1a expression enhances cardiac hypertrophy in pregnancy-associated hypertensive mice.
Journal: The Journal of biological chemistry
Published: February 27, 2022
Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation.
Journal: Stem cell research
Published: February 21, 2022
Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets.
Journal: Life sciences
Published: February 08, 2022
Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats.
Journal: Clinical science (London, England : 1979)
Published: April 23, 2021
Neutrophil Elastase Deficiency Ameliorates Myocardial Injury Post Myocardial Infarction in Mice.
Journal: International journal of molecular sciences
Published: December 31, 2020
Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice.
Journal: International journal of molecular sciences
Published: December 31, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026